Overview Traws Pharma, Inc. (Traws, we, or the Company) is a clinical stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. We are advancing novel investigational antiviral agents that have potent activity against difficult to treat or resistant virus strains that threaten human health. Our product candidates are intended to be safe, with simple dosing regimens. We strive to utilize accelerated clinical t...
Q2 FY2026 — expected 2026-09-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-03-31 | 2024-12-31 | 0001558370-25-004165 | EDGAR | 77K words |
| 2024-04-01 | 2023-12-31 | 0001558370-24-004525 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001558370-23-005107 | EDGAR | — |
| 2022-03-21 | 2021-12-31 | 0001558370-22-004015 | EDGAR | — |
| 2021-03-18 | 2020-12-31 | 0001104659-21-038452 | EDGAR | — |
| 2020-03-27 | 2019-12-31 | 0001047469-20-001878 | EDGAR | — |
| 2019-04-01 | 2018-12-31 | 0001047469-19-001839 | EDGAR | — |
| 2018-03-16 | 2017-12-31 | 0001047469-18-001777 | EDGAR | — |
| 2017-03-29 | 2016-12-31 | 0001047469-17-002146 | EDGAR | — |
| 2016-03-28 | 2015-12-31 | 0001047469-16-011628 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001104659-25-110845 | EDGAR | 26K words |
| 2025-08-14 | 2025-06-30 | 0001558370-25-011469 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001558370-25-007872 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001558370-24-015752 | EDGAR | — |
| 2024-08-15 | 2024-06-30 | 0001558370-24-012279 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001558370-24-008326 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001558370-23-019049 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001558370-23-014933 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001558370-23-009964 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001558370-22-017811 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001558370-22-013675 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001558370-22-008762 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-19 | 0001104659-26-017298 | EDGAR | 1K words |
| 2026-01-26 | 0001104659-26-006460 | EDGAR | — |
| 2026-01-13 | 0001104659-26-003071 | EDGAR | — |
| 2025-12-17 | 0001104659-25-121749 | EDGAR | — |
| 2025-12-16 | 0001104659-25-121635 | EDGAR | — |
| 2025-11-28 | 0001104659-25-116962 | EDGAR | — |
| 2025-11-13 | 0001104659-25-110829 | EDGAR | — |
| 2025-10-17 | 0001104659-25-100455 | EDGAR | — |
| 2025-10-14 | 0001104659-25-098994 | EDGAR | — |
| 2025-10-06 | 0001104659-25-096920 | EDGAR | — |
338 total filings indexed. 306 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001130598 |
| Ticker | TRAW |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.trawspharma.com |
| Listed | 2013-07-25 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report